Medtronic gets approval for platelet assay:
This article was originally published in Clinica
Medtronic has received US FDA marketing clearance for its HemoStatus platelet function test. The assay will be marketed worldwide as a family of disposable, six-channel cartridges for the company's Hepcon haemostasis management system. The initial marketing target will be cardiopulmonary bypass, but Medtronic's blood management unit hopes to expand applications to include other cardiac settings and clinical laboratories.